DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Aartsma-Rus A.
FDA approval of nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides.
Nucleic Acid Ther 2017;
27 (02) 67-69
We do not assume any responsibility for the contents of the web pages of other providers.